Tor Vergata University of Rome, also known as the University of Rome II, is a public research university located in Rome, Italy.

During the past decade, University of Rome Tor Vergata conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Rome Tor Vergata" #1 collaborator was "University of Bari" with 2 trials as a collaborator, "University of Rome Tor Vergata" with 2 trials as a collaborator, "ASST Santi Paolo e Carlo" with 1 trials as a collaborator, "Agnelli Hospital, Italy" with 1 trials as a collaborator and "Azienda Ospedaliera Universitaria Policlinico "G. Martino"" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "University of Rome Tor Vergata" are "Metabolic Syndrome" (2 trials), "Anastomotic Leak" (1 trials), "Autism Spectrum Disorder" (1 trials), "COVID-19" (1 trials) and "Colon Cancer" (1 trials). Many other conditions were trialed in "University of Rome Tor Vergata" in a lesser frequency.

Most popular intervention types in "University of Rome Tor Vergata" are "Drug" (4 trials), "Device" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Banded RME (Rapid Maxillary Expander) appliance" (1 trials), "Bonded RME (Rapid Maxillary Expander) appliance" (1 trials), "Community-based pro-Active Monitoring Program" (1 trials) and "Conventional Right hemicolectomy (Non-CME)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Rome Tor Vergata" are 12 trials for "All" genders.

Currently, there are NaN active trials in "University of Rome Tor Vergata". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University of Rome Tor Vergata, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Rome Tor Vergata, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".